BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 33712077)

  • 1. Fluid proteomics of CSF and serum reveal important neuroinflammatory proteins in blood-brain barrier disruption and outcome prediction following severe traumatic brain injury: a prospective, observational study.
    Lindblad C; Pin E; Just D; Al Nimer F; Nilsson P; Bellander BM; Svensson M; Piehl F; Thelin EP
    Crit Care; 2021 Mar; 25(1):103. PubMed ID: 33712077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of Blood-Brain Barrier Integrity on Brain Protein Biomarker Clearance in Severe Traumatic Brain Injury: A Longitudinal Prospective Study.
    Lindblad C; Nelson DW; Zeiler FA; Ercole A; Ghatan PH; von Horn H; Risling M; Svensson M; Agoston DV; Bellander BM; Thelin EP
    J Neurotrauma; 2020 Jun; 37(12):1381-1391. PubMed ID: 32013731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of serum markers for blood-brain barrier disruption in traumatic brain injury.
    Blyth BJ; Farhavar A; Gee C; Hawthorn B; He H; Nayak A; Stöcklein V; Bazarian JJ
    J Neurotrauma; 2009 Sep; 26(9):1497-1507. PubMed ID: 19257803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lactic acid, neuron-specific enolase, and blood-brain barrier index after a severe traumatic brain injury: a prospective study.
    Lu W; Jiang C; Wang Z; Chen Y; Bai R; Yan G; Wang G; Ren H
    Br J Neurosurg; 2024 Apr; 38(2):220-224. PubMed ID: 33016150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential disruption of blood-brain barrier in severe traumatic brain injury.
    Saw MM; Chamberlain J; Barr M; Morgan MP; Burnett JR; Ho KM
    Neurocrit Care; 2014 Apr; 20(2):209-16. PubMed ID: 24233818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated serum ubiquitin carboxy-terminal hydrolase L1 is associated with abnormal blood-brain barrier function after traumatic brain injury.
    Blyth BJ; Farahvar A; He H; Nayak A; Yang C; Shaw G; Bazarian JJ
    J Neurotrauma; 2011 Dec; 28(12):2453-62. PubMed ID: 21428722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphonuclear (PMN) elastase in patients after severe traumatic brain injury.
    Postl LK; Bogner V; van Griensven M; Beirer M; Kanz KG; Egginger C; Biberthaler P; Kirchhoff C
    Eur J Med Res; 2018 Sep; 23(1):44. PubMed ID: 30219097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of blood-brain barrier disruption in patients with severe nonpenetrating traumatic brain injury requiring decompressive craniectomy.
    Ho KM; Honeybul S; Yip CB; Silbert BI
    J Neurosurg; 2014 Sep; 121(3):674-9. PubMed ID: 25036202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time course of cerebrospinal fluid inflammatory biomarkers and relationship to 6-month neurologic outcome in adult severe traumatic brain injury.
    Nwachuku EL; Puccio AM; Adeboye A; Chang YF; Kim J; Okonkwo DO
    Clin Neurol Neurosurg; 2016 Oct; 149():1-5. PubMed ID: 27450760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-traumatic hypoxia is associated with prolonged cerebral cytokine production, higher serum biomarker levels, and poor outcome in patients with severe traumatic brain injury.
    Yan EB; Satgunaseelan L; Paul E; Bye N; Nguyen P; Agyapomaa D; Kossmann T; Rosenfeld JV; Morganti-Kossmann MC
    J Neurotrauma; 2014 Apr; 31(7):618-29. PubMed ID: 24279428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal response profiles of serum ubiquitin C-terminal hydrolase-L1 and the 145-kDa alpha II-spectrin breakdown product after severe traumatic brain injury in children.
    Metzger RR; Sheng X; Niedzwecki CM; Bennett KS; Morita DC; Zielinski B; Schober ME
    J Neurosurg Pediatr; 2018 Oct; 22(4):369-374. PubMed ID: 29957142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-lasting blood-brain barrier dysfunction and neuroinflammation after traumatic brain injury.
    van Vliet EA; Ndode-Ekane XE; Lehto LJ; Gorter JA; Andrade P; Aronica E; Gröhn O; Pitkänen A
    Neurobiol Dis; 2020 Nov; 145():105080. PubMed ID: 32919030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Principal components derived from CSF inflammatory profiles predict outcome in survivors after severe traumatic brain injury.
    Kumar RG; Rubin JE; Berger RP; Kochanek PM; Wagner AK
    Brain Behav Immun; 2016 Mar; 53():183-193. PubMed ID: 26705843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphine attenuates neuroinflammation and blood-brain barrier disruption following traumatic brain injury through the opioidergic system.
    Rahimi S; Dadfar B; Tavakolian G; Asadi Rad A; Rashid Shabkahi A; Siahposht-Khachaki A
    Brain Res Bull; 2021 Nov; 176():103-111. PubMed ID: 34464684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RANTES levels in peripheral blood, CSF and contused brain tissue as a marker for outcome in traumatic brain injury (TBI) patients.
    Albert V; Subramanian A; Agrawal D; Bhoi SK; Pallavi P; Mukhopadhayay AK
    BMC Res Notes; 2017 Mar; 10(1):139. PubMed ID: 28340601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal Fluid and Blood Biomarkers of Neuroinflammation and Blood-Brain Barrier in Psychotic Disorders and Individually Matched Healthy Controls.
    Jeppesen R; Orlovska-Waast S; Sørensen NV; Christensen RHB; Benros ME
    Schizophr Bull; 2022 Nov; 48(6):1206-1216. PubMed ID: 35939296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrathecal levels of complement-derived soluble membrane attack complex (sC5b-9) correlate with blood-brain barrier dysfunction in patients with traumatic brain injury.
    Stahel PF; Morganti-Kossmann MC; Perez D; Redaelli C; Gloor B; Trentz O; Kossmann T
    J Neurotrauma; 2001 Aug; 18(8):773-81. PubMed ID: 11526983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting Clinical Outcomes 7-10 Years after Severe Traumatic Brain Injury: Exploring the Prognostic Utility of the IMPACT Lab Model and Cerebrospinal Fluid UCH-L1 and MAP-2.
    Svingos AM; Robicsek SA; Hayes RL; Wang KK; Robertson CS; Brophy GM; Papa L; Gabrielli A; Hannay HJ; Bauer RM; Heaton SC
    Neurocrit Care; 2022 Aug; 37(1):172-183. PubMed ID: 35229233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal proteomics of human cerebrospinal fluid after severe traumatic brain injury.
    Shultz SR; Shah AD; Huang C; Dill LK; Schittenhelm RB; Morganti-Kossmann MC; Semple BD
    J Neuroinflammation; 2022 Dec; 19(1):291. PubMed ID: 36482407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptosis in cerebrospinal fluid as outcome predictors in severe traumatic brain injury: An observational study.
    Jiang W; Jin P; Wei W; Jiang W
    Medicine (Baltimore); 2020 Jun; 99(26):e20922. PubMed ID: 32590803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.